Clinical Trial Update: Atrovastatin for Preventing Atrial Fibrillation Following Open Cardiac Valve Repair [Phase 3]

View source ↗

Summary

Phase 3 trial of atorvastatin for preventing atrial fibrillation after open cardiac valve repair has completed and results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Heart Valve Diseases

Drugs mentioned

• atorvastatin (atorvastatin)

Snippet

Sponsor: Urmia University of Medical Sciences | Conditions: Heart Valve Diseases | Phase 3 | Status: COMPLETED | Results posted: 2015-02-04